Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipoproteins, LDL | 4 | 2012 | 343 | 0.580 |
Why?
|
| Central Nervous System Diseases | 2 | 2014 | 40 | 0.560 |
Why?
|
| Sarcoidosis | 2 | 2014 | 77 | 0.540 |
Why?
|
| Immediate-Early Proteins | 2 | 2005 | 63 | 0.500 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2005 | 146 | 0.480 |
Why?
|
| Transforming Growth Factor beta | 2 | 2005 | 384 | 0.270 |
Why?
|
| Collagen Type IV | 1 | 2005 | 28 | 0.260 |
Why?
|
| Glomerular Mesangium | 1 | 2005 | 53 | 0.250 |
Why?
|
| Aorta | 1 | 2005 | 316 | 0.230 |
Why?
|
| Connective Tissue Growth Factor | 3 | 2012 | 76 | 0.220 |
Why?
|
| Endothelial Cells | 1 | 2005 | 384 | 0.210 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 102 | 0.140 |
Why?
|
| Radiography | 2 | 2014 | 572 | 0.130 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 517 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2014 | 2673 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 415 | 0.120 |
Why?
|
| Hydantoins | 1 | 2014 | 5 | 0.120 |
Why?
|
| Bradykinin | 1 | 2014 | 157 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 144 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2014 | 244 | 0.110 |
Why?
|
| Lymph Nodes | 1 | 2014 | 258 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 186 | 0.100 |
Why?
|
| Glucose | 1 | 2014 | 307 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 317 | 0.100 |
Why?
|
| Mesangial Cells | 1 | 2012 | 37 | 0.100 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2012 | 63 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 226 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2012 | 201 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 514 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 682 | 0.080 |
Why?
|
| Lung | 1 | 2014 | 849 | 0.080 |
Why?
|
| Retinal Vessels | 1 | 2009 | 74 | 0.080 |
Why?
|
| Pericytes | 1 | 2009 | 81 | 0.070 |
Why?
|
| Diabetic Nephropathies | 2 | 2012 | 161 | 0.070 |
Why?
|
| Rats | 3 | 2014 | 5300 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2005 | 126 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2005 | 175 | 0.060 |
Why?
|
| Young Adult | 1 | 2014 | 5717 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2003 | 86 | 0.050 |
Why?
|
| Middle Aged | 3 | 2017 | 21147 | 0.050 |
Why?
|
| Apoptosis | 1 | 2009 | 1641 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2003 | 195 | 0.050 |
Why?
|
| Humans | 6 | 2017 | 68618 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1293 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2012 | 247 | 0.040 |
Why?
|
| Adult | 2 | 2014 | 21403 | 0.040 |
Why?
|
| Male | 4 | 2014 | 37321 | 0.040 |
Why?
|
| Animals | 4 | 2014 | 20881 | 0.040 |
Why?
|
| Female | 3 | 2017 | 38074 | 0.040 |
Why?
|
| Hydroxyl Radical | 1 | 2014 | 17 | 0.030 |
Why?
|
| Cranial Nerve Diseases | 1 | 2012 | 14 | 0.030 |
Why?
|
| Age of Onset | 1 | 2012 | 188 | 0.030 |
Why?
|
| Headache | 1 | 2012 | 68 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2012 | 137 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 246 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 280 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 901 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2012 | 98 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 540 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2012 | 209 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 376 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2012 | 525 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 434 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1745 | 0.020 |
Why?
|
| Sphingosine | 1 | 2012 | 315 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 3705 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1174 | 0.020 |
Why?
|
| Butadienes | 1 | 2009 | 26 | 0.020 |
Why?
|
| Anthracenes | 1 | 2009 | 26 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 2083 | 0.020 |
Why?
|
| Nitriles | 1 | 2009 | 68 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 140 | 0.020 |
Why?
|
| Capillaries | 1 | 2009 | 105 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 134 | 0.020 |
Why?
|
| Imidazoles | 1 | 2009 | 175 | 0.020 |
Why?
|
| Glycation End Products, Advanced | 1 | 2009 | 125 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 175 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1664 | 0.020 |
Why?
|
| Pyridines | 1 | 2009 | 261 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 331 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 1200 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2223 | 0.010 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2003 | 6 | 0.010 |
Why?
|
| Basement Membrane | 1 | 2003 | 48 | 0.010 |
Why?
|
| Streptozocin | 1 | 2003 | 34 | 0.010 |
Why?
|
| Cytidine Deaminase | 1 | 2003 | 17 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 2003 | 72 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 351 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 137 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2003 | 80 | 0.010 |
Why?
|
| Albuminuria | 1 | 2003 | 171 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2003 | 186 | 0.010 |
Why?
|
| Lipids | 1 | 2003 | 298 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 7029 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 4655 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 7277 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 636 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2003 | 1692 | 0.010 |
Why?
|
| Kidney | 1 | 2003 | 945 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 14862 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 2550 | 0.010 |
Why?
|
| Mice | 1 | 2003 | 8474 | 0.010 |
Why?
|